Sonoma Pharmaceuticals Inc (SNOA) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sonoma Pharmaceuticals Inc   (NASDAQ: SNOA)


Sonoma Pharmaceuticals Inc's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sonoma Pharmaceuticals Inc's ROI in the first quarter of 2026?
Sonoma Pharmaceuticals Inc recorded a cumulative net loss of $-2 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -22.13%.

Within the Healthcare sector 273 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2026 from 2457 to 3942.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter
Y / Y Investment Change TTM 0.44 % -7.11 % -9.13 % -8.98 % -7.1 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 13 9 10 10 10
Return On Investment (TTM) -22.13 % -33.42 % -35.04 % -34.88 % -34.9 %
SNOA's Overall Ranking # 3942 # 2457 # 2970 # 2766 #
Seq. Investment Change TTM 7.67 % -1.22 % -3.57 % -2.07 % -0.43 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -2 -3 -3 -3 -4

SNOA Company Profile >> Back to SNOA Roi Comparisons >> See Annual SNOA Return On Investment



Return On Investment SNOA's Ranking
Within: No.
Industry # 87
Sector # 274
Overall # 3942

Return On Investment Statistics
High Average Low
102.39 %
-48.9 %
-259.89 %
(Dec 31 2016)   (Mar 31 2012)







Financial Statements
Sonoma Pharmaceuticals Inc's I. Quarter Investments $ 13 Millions SNOA's Balance sheet
Sonoma Pharmaceuticals Inc's I. Quarter Income $ 0 Millions Quarterly SNOA's Income Statement
SNOA's Income by Division See SNOA's Income by Division


SNOA Annual Return On Investment (Mar 31 2026)
2026		 (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2022)
2022
Total Investments in Millions 9 10 11 13 13
Y / Y Investment Growth -4.89 % -12.92 % -11.93 % -3.93 % 19.41 %
Net Income in Millions 0 -3 -5 -5 -5
Y / Y Net Income Growth - - - - -
Annual Return On Investment 0.03 % -36.02 % -43.87 % -41.16 % -39.04 %


Annual Roi Comment
In the fiscal year 2026 ROI improved to 0.03 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SNOA's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SNOA's Competitors
Subscribers only: Roi for Sonoma Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for SNOA's Customers

Other Ratios
SNOA's Roa SNOA's Inventory Turnover Ratio SNOA's Growth Rates SNOA's Dividend Statistics
SNOA's Profitability Ratios SNOA's Asset Turnover Ratio SNOA's Dividend Growth
SNOA's Roe SNOA's Valuation Ratios SNOA's Financial Strength Ratios SNOA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-05T15:31:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.